Skip to Content


National Cancer Institute; Amended Notice of Meeting

Document Details

Information about this document as published in the Federal Register.

Document Statistics
Document page views are updated periodically throughout the day and are cumulative counts for this document including its time on Public Inspection. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.
Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble Start Printed Page 32559

Notice is hereby given of a change in the meeting of the National Cancer Institute (NCI) Ad hoc Clinical Trials Strategic Planning Subcommittee of the NCI Clinical Trials and Translational Research Advisory Committee (CTAC), July 8, 2014, 2:00 p.m. to July 8, 2014, 3:00 p.m., National Cancer Institute Shady Grove, Shady Grove, 9609 Medical Center Drive, 6West CCCT Huddle Room, Rockville, MD, 20850 which was published in the Federal Register on May 8, 2014, 79 FR 26441.

This notice is being amended to change the meeting type to a webinar. The meeting will be open to the public. Pertinent information related to the webinar is as follows:

Go to:​cbiit/​j.php?​MTID=​m3d3b0b1886a6e7b32fbf568ae44f6915

Meeting Password: ctac.

Meeting Number: 735 128 827.

Audio Connection

1. Provide your number when you join the meeting to receive a call back. Alternatively, you can call the following number: Dial In Number: 1-240-276-6338.

2. Follow the instructions that you hear on the phone. Your Cisco Unified MeetingPlace meeting ID: 730 501 868.

Start Signature

Dated: May 31, 2014.

Melanie J. Gray,

Program Analyst, Office of Federal Advisory Committee Policy.

End Signature End Preamble

[FR Doc. 2014-13025 Filed 6-4-14; 8:45 am]